Aurinia Pharmaceuticals Inc.
AUPHNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for AUPH. That does not mean none is planned.
Get an email about AUPH's next catalysts
Track Aurinia Pharmaceuticals (AUPH) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
AUPH Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $0.20 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Voclosporin
Lupus Nephritis
Ciclosporin
Psoriasis
VOS
Dry Eye Syndrome
Voclosporin Ophthalmic Solution (VOS)
Dry Eye Syndrome
Voclosporin Low Dose
Lupus Nephritis
Voclosporin High Dose
Lupus Nephritis
Voclosporin Ophthalmic Solution
Dry Eye
Aritinercept
Myasthenia Gravis, Generalized
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Voclosporin | Phase 3 | Lupus Nephritis | - | - |
Ciclosporin | Phase 3 | Psoriasis | - | - |
VOS | Phase 3 | Dry Eye Syndrome | - | - |
Voclosporin Ophthalmic Solution (VOS) | Phase 3 | Dry Eye Syndrome | - | - |
Voclosporin Low Dose | Phase 2 | Lupus Nephritis | - | - |
Voclosporin High Dose | Phase 2 | Lupus Nephritis | - | - |
Voclosporin Ophthalmic Solution | Phase 2 | Dry Eye | - | - |
Aritinercept | Phase 2 | Myasthenia Gravis, Generalized | - | - |
Lupus Nephritis
3 drugs in this indication
Dry Eye Syndrome
2 drugs in this indication
Psoriasis
2 drugs in this indication
Dry Eye
1 drug in this indication
lupus
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Aurinia Pharmaceuticals Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in Aurinia Pharmaceuticals Inc.'s (AUPH) pipeline across Phase 3, Phase 2. Its lead program is Ciclosporin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Aurinia Pharmaceuticals Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Aurinia Pharmaceuticals Inc. (AUPH) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AUPH biotech catalysts?→
Add AUPH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Aurinia Pharmaceuticals Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.